These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12083597)

  • 1. Risperidone and 9-hydroxyrisperidone concentrations are not dependent on age or creatinine clearance among elderly subjects.
    Maxwell RA; Sweet RA; Mulsant BH; Rosen J; Kirshner MA; Kastango KB; Pollock BG
    J Geriatr Psychiatry Neurol; 2002; 15(2):77-81. PubMed ID: 12083597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of venlafaxine on the pharmacokinetics of risperidone.
    Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
    J Clin Pharmacol; 1999 Mar; 39(3):297-309. PubMed ID: 10073330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overdose of risperidone.
    Springfield AC; Bodiford E
    J Anal Toxicol; 1996; 20(3):202-3. PubMed ID: 8735204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.
    Aman MG; Vinks AA; Remmerie B; Mannaert E; Ramadan Y; Masty J; Lindsay RL; Malone K
    Clin Ther; 2007 Jul; 29(7):1476-86. PubMed ID: 17825699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate.
    Spina E; Avenoso A; Facciolà G; Salemi M; Scordo MG; Giacobello T; Madia AG; Perucca E
    Ther Drug Monit; 2000 Aug; 22(4):481-5. PubMed ID: 10942191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Kidney Function on Serum Risperidone Concentrations in Patients Treated With Risperidone.
    Gründer P; Augustin M; Paulzen M; Gründer G
    J Clin Psychiatry; 2019 Nov; 80(6):. PubMed ID: 31774943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic drug monitoring of risperidone and its active metabolite 9-hydroxyrisperidone in the treatment of schizophrenia].
    Baymeeva NV; Platova AI; Kaleda VG; Miroshnichenko II
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3):24-28. PubMed ID: 31089091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes.
    Yasui-Furukori N; Mihara K; Takahata T; Suzuki A; Nakagami T; De Vries R; Tateishi T; Kondo T; Kaneko S
    Br J Clin Pharmacol; 2004 May; 57(5):569-75. PubMed ID: 15089809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated LC-MS/MS methods for the determination of risperidone and the enantiomers of 9-hydroxyrisperidone in human plasma and urine.
    De Meulder M; Remmerie BM; de Vries R; Sips LL; Boom S; Hooijschuur EW; van de Merbel NC; Timmerman PM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):8-16. PubMed ID: 18571483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age and gender on risperidone plasma concentrations.
    Aichhorn W; Weiss U; Marksteiner J; Kemmler G; Walch T; Zernig G; Stelzig-Schoeler R; Stuppaeck C; Geretsegger C
    J Psychopharmacol; 2005 Jul; 19(4):395-401. PubMed ID: 15982995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MultiSimplex optimization of chromatographic separation and dansyl derivatization conditions in the ultra performance liquid chromatography-tandem mass spectrometry analysis of risperidone, 9-hydroxyrisperidone, monoamine and amino acid neurotransmitters in human urine.
    Cai HL; Zhu RH; Li HD; Zhang J; Li LF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1993-9. PubMed ID: 21621490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study.
    Uchida H; Mamo DC; Pollock BG; Suzuki T; Tsunoda K; Watanabe K; Mimura M; Bies RR
    Ther Drug Monit; 2012 Apr; 34(2):182-7. PubMed ID: 22377743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of risperidone and 9-hydroxyrisperidone in plasma by high performance liquid chromatography].
    Xiao H; Yang J; Zhang S; Zhang X
    Se Pu; 1999 Jul; 17(4):395-6. PubMed ID: 12552862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic patterns of risperidone-associated adverse drug reactions.
    Schoretsanitis G; Stegmann B; Hiemke C; Gründer G; Schruers KR; Walther S; Lammertz SE; Haen E; Paulzen M
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1091-8. PubMed ID: 27376639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of risperidone and 9-hydroxyrisperidone in plasma, urine and animal tissues by high-performance liquid chromatography.
    Woestenborghs R; Lorreyne W; Van Rompaey F; Heykants J
    J Chromatogr; 1992 Dec; 583(2):223-30. PubMed ID: 1282517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone.
    Aravagiri M; Marder SR; Nuechterlein KH; Gitlin MJ
    Ther Drug Monit; 2003 Dec; 25(6):657-64. PubMed ID: 14639051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia.
    Gopal S; Gassmann-Mayer C; Palumbo J; Samtani MN; Shiwach R; Alphs L
    Curr Med Res Opin; 2010 Feb; 26(2):377-87. PubMed ID: 20001492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of smoking on risperidone pharmacokinetics - A multifactorial approach to better predict the influence on drug metabolism.
    Schoretsanitis G; Haen E; Stegmann B; Hiemke C; Gründer G; Paulzen M
    Schizophr Res; 2017 Jul; 185():51-57. PubMed ID: 27993531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia.
    Gefvert O; Eriksson B; Persson P; Helldin L; Björner A; Mannaert E; Remmerie B; Eerdekens M; Nyberg S
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):27-36. PubMed ID: 15710053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the ABCB1 gene polymorphism on plasma 9-hydroxyrisperidone and active moiety levels in Japanese patients with schizophrenia.
    Suzuki Y; Tsuneyama N; Fukui N; Sugai T; Watanabe J; Ono S; Saito M; Someya T
    J Clin Psychopharmacol; 2013 Jun; 33(3):411-4. PubMed ID: 23609388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.